NR4A1 and breast carcinoma: This phenomenon can be partially attributed to the greater frequency of hormonal receptor/HER2-negative tumors in this group compared with late-onset breast cancer patients [12] in addition to poor differentiation, lymphovascular invasion and high proliferative fraction [10], [13].